Trichomonas vaginalis genital infections: Progress and challenges

Clinical Infectious Diseases

Volumn 53, Issue SUPPL. 3, 2011, Pages

  Bachmann, Laura H ^a,b   Hobbs, Marcia M ^c   Seña, Arlene C ^d   Sobel, Jack D ^e   Schwebke, Jane R ^f   Krieger, John N ^g,h   McClelland, R Scott ^g   Workowski, Kimberly A ^i,j  

^a Infectious Diseases Section   (United Kingdom)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c Departments of Medicine Microbiology and Immunology ^*  (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f University of Alabama at Birmingham   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FURAZOLIDONE; METRONIDAZOLE; NITROIMIDAZOLE; NONOXINOL 9; ORNIDAZOLE; PAROMOMYCIN; POVIDONE IODINE; TINIDAZOLE;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; DESENSITIZATION; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TREATMENT FAILURE; FACE EDEMA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNSPECIFIED SIDE EFFECT; URETHRITIS; URTICARIA; VIRUS SHEDDING;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; UNITED STATES; YOUNG ADULT;

EID: 81055133506     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir705     Document Type: Review

References (73)

1. World Health Organization (WHO). Global prevalence and incidence of selected curable sexually transmitted infections overview and estimates. Geneva: WHO, 2001.
2. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007; 45:1319-26. (Pubitemid 351411908)
3. Helms DJ, Mosure DJ, Metcalf CA, et al. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sex Transm Dis 2008; 35:484-8. (Pubitemid 351670550)
4. Joyner JL, Douglas JM Jr, Ragsdale S, FosterM, Judson FN. Comparative prevalence of infection with Trichomonas vaginalis amongmen attending a sexually transmitted diseases clinic. Sex Transm Dis 2000; 27:236-40. (Pubitemid 30210803)
5. Khan A, Fortenberry JD, Juliar BE, Tu W, Orr DP, Batteiger BE. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Transm Dis 2005; 32:260-4. (Pubitemid 40411586)
6. Schwebke JR, Hook EW 3rd. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003; 188:465-8. (Pubitemid 36960659)
7. Sturm PD, Moodley P, Khan N, et al. Aetiology of male urethritis in patients recruited from a population with a high HIV prevalence. Int J Antimicrob Agents 2004; 24(suppl 1):S8-14. (Pubitemid 39208853)
8. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect 2003; 79:151-3. (Pubitemid 36469623)
9. Brogly SB, Watts DH, Ylitalo N, et al. Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health 2007; 97:1047-52. (Pubitemid 351181927)
10. Cu-Uvin S, Ko H, Jamieson DJ, et al. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis 2002; 34:1406-11. (Pubitemid 34507952)
11. Magnus M, Clark R, Myers L, Farley T, Kissinger PJ. Trichomonas vaginalis among HIV-infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis 2003; 30:839-43. (Pubitemid 37386215)
12. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.
13. Miller M, Liao Y, Wagner M, Korves C. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex Transm Dis 2008; 35:696-702.
14. Moodley P, Wilkinson D, Connolly C, Sturm AW. Influence of HIV-1 coinfection on effective management of abnormal vaginal discharge. Sex Transm Dis 2003; 30:1-5. (Pubitemid 36071076)
15. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922-7. (Pubitemid 27420529)
16. Seth P, Wingood GM, Diclemente RJ. Exposure to alcohol problems and its association with sexual behaviour and biologically confirmed Trichomonas vaginalis among women living with HIV. Sex Transm Infect 2008; 84:390-2.
17. Watts DH, Springer G, Minkoff H, et al. The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2006; 43:161-8. (Pubitemid 44454809)
18. Kingston MA, Bansal D, Carlin EM. 'Shelf life' of Trichomonas vaginalis. Int J STD AIDS 2003; 14:28-9.
19. Borchardt KA, Zhang MZ, Shing H, Flink K. A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis. Genitourin Med 1997; 73:297-8. (Pubitemid 27376696)
20. Hobbs MM, Lapple DM, Lawing LF, et al. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J Clin Microbiol 2006; 44:3994-9. (Pubitemid 44737241)
21. Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988; 259:1223-7. (Pubitemid 18058836)
22. Stary A, Kuchinka-Koch A, Teodorowicz L. Detection of Trichomonas vaginalis on modified Columbia agar in the routine laboratory. J Clin Microbiol 2002; 40:3277-80. (Pubitemid 34977440)
23. Lawing LF, Hedges SR, Schwebke JR. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol 2000; 38:3585-8.
24. Mohamed OA, Cohen CR, Kungu D, et al. Urine proves a poor specimen for culture of Trichomonas vaginalis in women. Sex Transm Infect 2001; 77:78-9. (Pubitemid 32142799)
25. Schwebke JR, Morgan SC, Pinson GB. Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J Clin Microbiol 1997; 35:1618-9. (Pubitemid 27216850)
26. Swygard H, Miller WC, Kaydos-Daniels SC, et al. Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis 2004; 31: 659-64. (Pubitemid 39426397)
27. Lara-Torre E, Pinkerton JS. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear. Am J Obstet Gynecol 2003; 188:354-6. (Pubitemid 36249970)
28. Briselden AM, Hillier SL. Evaluation of affirm VP Microbial Identification test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol 1994; 32:148-52.
29. Demeo LR, Draper DL, McGregor JA, et al. Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions. Am J Obstet Gynecol 1996; 174:1339-42. (Pubitemid 26131158)
30. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005; 43:684-7. (Pubitemid 40256019)
31. Hardick A, Hardick J, Wood BJ, Gaydos C. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J Clin Microbiol 2006; 44:4197-9. (Pubitemid 44737270)
32. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 2007; 45:194-8. (Pubitemid 47041010)
33. Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 2009; 200:188-7.
34. Hardick A, Wood BJ, Hardick J, et al. Comparison of cervical samples to vaginal samples for the detection of Trichomonas vaginalis using a Gen-Probe research assay for rRNA. In: 2005 American Society of Microbiology Annual Meeting, 2009.
35. Hobbs MM, Rich KD, Lapple DM, Lau K, Sousa S, Sena AC. Endocervical and vaginal specimens are comparable for detection of Trichomonas vaginalis using transcription-mediated amplication (TMA). Submitted for 2009 ISSTDR, 2009.
36. Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol 2006; 44:366-73. (Pubitemid 43222224)
37. Wood BA, Monro AM. Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. Br J Vener Dis 1975; 51: 51-3.
38. Mannisto P, Karhunen M, Mattila J, et al. Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration. Infection 1984; 12:197-201. (Pubitemid 14089022)
39. Viitanen J, Haataja H, Mannisto PT. Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother 1985; 28:812-4. (Pubitemid 16196920)
40. Anjaeyulu R, Gupte SA, Desai DB. Single-dose treatment of trichomonal vaginitis: a comparison of tinidazole and metronidazole. J Int Med Res 1977; 5:438-41. (Pubitemid 8220597)
41. Begum SF, Alid SE, Ali S. Short course nitroimidazole in the treatment of vaginal trichomoniasis. Curr Ther Res 1980; 28:922-6. (Pubitemid 11210685)
42. Bloch B, Smyth E. The treatment of Trichomonas vaginalis vaginitis: an open controlled prospective study comparing a single dose of metronidazole tablets, benzoyl metronidazole suspension and tinidazole tablets. S Afr Med J 1985; 67:455-7. (Pubitemid 15025821)
43. Gabriel G, Robertson E, Thin RN. Single dose treatment of trichomoniasis. J Int Med Res 1982; 10:129-30. (Pubitemid 12133735)
44. Garud M, Lulla M, Saraiya U, Vaidya S. Single-dose oral treatment of vaginal trichomoniasis with tinidazole and metronidazole. J Obstet Gynaecol 1978; 28:347-50.
45. Manorama HT, Shenoy DR. Single-dose oral treatment of vaginal trichomoniasis with tinidazole and metronidazole. J Int Med Res 1978; 6:46-9. (Pubitemid 8274309)
46. Prasertsawat P, Jetsawangsri T. Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex Transm Dis 1992; 19:295-7.
47. Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003: CD000218.
48. Kawamura N. Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in men. Br J Vener Dis 1978; 54:81-3. (Pubitemid 8315718)
49. Wallin JE, Thompson SE, Zaidi A, Wong KH. Urethritis in women attending an STD clinic. Br J Vener Dis 1981; 57:50-4. (Pubitemid 11147703)
50. Massa M, Arias B, Subiabre V, Rojo M. Therapeutic trial of Trichomonas vaginalis in male by using a single dose of tinidazole [author's translation]. Bol Chil Parasitol 1976; 31:46-7.
51. Schwebke JR, Rompalo A, Taylor S, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens-a randomized clinical trial. Clin Infect Dis 2011; 52:163-70.
52. Morency P, DuboisMJ, Gresenguet G, et al. Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Infect 2001; 77:125-9. (Pubitemid 32324485)
53. Price MA, Zimba D, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis 2003; 30:516-22. (Pubitemid 36667033)
54. Saurina G, DeMeo L, McCormack WM. Cure of metronidazole-and tinidazole-resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole. Clin Infect Dis 1998; 26:1238-9. (Pubitemid 28215503)
55. Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001; 46:545-9. (Pubitemid 32592196)
56. Crowell AL, Sanders-Lewis KA, Secor WE. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother 2003; 47:1407-9. (Pubitemid 36368606)
57. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazoleresistant vaginal trichomoniasis. Clin Infect Dis 2001; 33:1341-6. (Pubitemid 32955184)
58. Hamed KA, Studemeister AE. Successful response of metronidazoleresistant trichomonal vaginitis to tinidazole: a case report. Sex Transm Dis 1992; 19:339-40. (Pubitemid 23012466)
59. Helms DJ, Mosure DJ, Secor WE, Workowski KA. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 2008; 198:370-7.
60. Waters LJ, Dave SS, Deayton JR, French PD. Recalcitrant Trichomonas vaginalis infection-a case series. Int J STD AIDS 2005; 16:505-9. (Pubitemid 41003156)
61. Lossick JG. Treatment of sexually transmitted vaginosis/vaginitis. Rev Infect Dis 1990; 12(suppl 6):S665-81. (Pubitemid 20220344)
62. Kissinger P, Secor WE, Leichliter JS, et al. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis 2008; 46:994-9. (Pubitemid 351589863)
63. Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002; 34:519-22. (Pubitemid 34112274)
64. Kissinger P, Mena L, Levison J, et al. A randomized treatment trial: single versus 7 day dose of metroidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr 2010; 55:565-71.
65. Price MA, Miller WC, Kaydos-Daniels SC, et al. Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi. J Infect Dis 2004; 190:1448-55. (Pubitemid 39332184)
66. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type, J Infect Dis 2001; 183:1017-22. (Pubitemid 32230948)
67. Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm.Dis 2009; 36: 11-6.
68. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344:246-8.
69. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548-54. (Pubitemid 351321532)
70. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:651-81.
71. Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145: 564-72. (Pubitemid 46780935)
72. Hitti J, Nugent R, Boutain D, Gardella C, Hillier SL, Eschenbach DA. Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr Perinat Epidemiol 2007; 21:330-7. (Pubitemid 46905336)
73. Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006; 50:4209-10. (Pubitemid 44865173)